Clinical trial

Sirolimus vs Mycophenolate With Tacrolimus in Simultaneous Pancreas and Kidney Transplantation

NCT03582878

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Sirolimus Oral Product Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Mycophenolate Mofetil Normalized identity: mycophenolate mofetilView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Sirolimus vs Mycophenolate With Tacrolimus in Simultaneous Pancreas and Kidney Transplantation

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-01-01

PhasePHASE4

Conditions

Diabetes Mellitus, Type 1unresolved

Interventions

Sirolimus Oral ProductDRUG

Mycophenolate MofetilDRUG · verified · RxNorm: mycophenolate mofetil

Sponsors & collaborators

Institute for Clinical and Experimental Medicinelead sponsor

Mapped research locations

PragueCzechia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03582878 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.